EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Somatostatin Containing δ-Cell Number Is Reduced in Type-2 Diabetes

Lakshmi Kothegala, Caroline Miranda, Meetu Singh, Jean-Philippe Krieger, Nikhil R Gandasi

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24043449 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Lakshmi Kothegala und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cell Metabolism Lab (GA-08), Department of Developmental Biology and Genetics (DBG), Indian Institute of Science (IISc), Bengaluru 560012, India. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Islets of Langerhans. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Strategic Foundation—Mobility grant, European Foundation for the Study of Diabetes—Rising Star Award grant, NovoNordisk Foundation grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent developments suggest that increased glucagon and decreased somatostatin secretion from the pancreas contribute to hyperglycaemia in type-2 diabetes (T2D) patients. There is a huge need to understand changes in glucagon and somatostatin secretion to develop potential anti-diabetic drugs. To further describe the role of somatostatin in the pathogenesis of T2D, reliable means to detect islet δ-cells and somatostatin secretion are necessary. In this study, we first tested currently available anti-somatostatin antibodies against a mouse model that fluorescently labels δ-cells. We found that these antibodies only label 10–15% of the fluorescently labelled δ-cells in pancreatic islets. We further tested six antibodies (newly developed) that can label both somatostatin 14 (SST14) and 28 (SST28) and found that four of them were able to detect above 70% of the fluorescent cells in the transgenic islets. This is quite efficient compared to the commercially available antibodies. Using one of these antibodies (SST10G5), we compared the cytoarchitecture of mouse and human pancreatic islets and found fewer δ-cells in the periphery of human islets. Interestingly, the δ-cell number was also reduced in islets from T2D donors compared to non-diabetic donors. Finally, with the aim to measure SST secretion from pancreatic islets, one of the candidate antibodies was used to develop a direct-ELISA-based SST assay. Using this novel assay, we could detect SST secretion under low and high glucose conditions from the pancreatic islets, both in mice and humans. Overall, using antibody-based tools provided by Mercodia AB, our study indicates reduced δ-cell numbers and SST secretion in diabetic islets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Islets of LangerhansHumansCell CountGlucagonInsulinSomatostatin

Stichwörter der Autor:innen

Confocal microscopyType-2-Diabetesislet-hormone secretionmulti-photon imagingpancreatic islets

Substanzen

GlucagonInsulinSomatostatinSST protein, human

Autor:innen und Institutionen

  • Cell Metabolism Lab (GA-08), Department of Developmental Biology and Genetics (DBG), Indian Institute of Science (IISc), Bengaluru 560012, India.
  • Department of Metabolic Physiology, Institute of Neuroscience and Physiology, University of Gothenburg, Box 430, 40530 Gothenburg, Sweden.
  • Department of Medical Cell Biology, Uppsala University, BMC 571, 75123 Uppsala, Sweden.

Förderung

  • Swedish Strategic Foundation—Mobility grant
  • European Foundation for the Study of Diabetes—Rising Star Award grant
  • NovoNordisk Foundation grant
  • DBT Ramalingaswamy grant
  • Indian Council of Medical Research (ICMR)
  • IISc Startup grant

Zitieren

APA

Kothegala, L., Miranda, C., Singh, M., Krieger, J. P., & Gandasi, N. R. (2023). Somatostatin Containing δ-Cell Number Is Reduced in Type-2 Diabetes. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24043449

Vancouver

Kothegala L, Miranda C, Singh M, Krieger JP, Gandasi NR. Somatostatin Containing δ-Cell Number Is Reduced in Type-2 Diabetes. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24043449

BibTeX
@article{Kothegala2023,
  author = {Kothegala, Lakshmi and Miranda, Caroline and Singh, Meetu and Krieger, Jean-Philippe and Gandasi, Nikhil R},
  title = {Somatostatin Containing δ-Cell Number Is Reduced in Type-2 Diabetes},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24043449}
}
Kostenlos starten →